| pubmed-article:19596702 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19596702 | lifeskim:mentions | umls-concept:C0278493 | lld:lifeskim |
| pubmed-article:19596702 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:19596702 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:19596702 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:19596702 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19596702 | pubmed:dateCreated | 2009-11-25 | lld:pubmed |
| pubmed-article:19596702 | pubmed:abstractText | We evaluated discordance in expression measurements for estrogen receptor (ER), progesterone receptor (PR), and HER2 between primary and recurrent tumors in patients with recurrent breast cancer and its effect on prognosis. | lld:pubmed |
| pubmed-article:19596702 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19596702 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19596702 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19596702 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19596702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19596702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19596702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19596702 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19596702 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19596702 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:IUSAA | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:HortobagyiG... | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:WoodwardWW | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:LiedtkeCC | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:KieselLL | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:TheriaultR... | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:PusztaiLL | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:AlbarracinCC | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:SymmansW FWF | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:MoulderSS | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:Meric-Bernsta... | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:Gonzalez-Angu... | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:BroglioKK | lld:pubmed |
| pubmed-article:19596702 | pubmed:author | pubmed-author:KauS-WSW | lld:pubmed |
| pubmed-article:19596702 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19596702 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:19596702 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19596702 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19596702 | pubmed:pagination | 1953-8 | lld:pubmed |
| pubmed-article:19596702 | pubmed:dateRevised | 2011-3-3 | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:meshHeading | pubmed-meshheading:19596702... | lld:pubmed |
| pubmed-article:19596702 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19596702 | pubmed:articleTitle | Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. | lld:pubmed |
| pubmed-article:19596702 | pubmed:affiliation | Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77039, USA. | lld:pubmed |
| pubmed-article:19596702 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19596702 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19596702 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19596702 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19596702 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19596702 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19596702 | lld:pubmed |
